ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 164 filers reported holding ADMA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $867 | +82.1% | 242,284 | +87.7% | 0.07% | +54.2% |
| Q2 2023 | $476 | +113.5% | 129,100 | +91.3% | 0.05% | +118.2% |
| Q1 2023 | $223 | -65.8% | 67,474 | -59.9% | 0.02% | -72.8% |
| Q4 2022 | $653 | -99.5% | 168,422 | +74.4% | 0.08% | +376.5% |
| Q4 2021 | $136,000 | -80.1% | 96,578 | -84.0% | 0.02% | -75.7% |
| Q3 2021 | $684,000 | -50.3% | 605,237 | -29.7% | 0.07% | -54.8% |
| Q2 2021 | $1,377,000 | +42.4% | 860,911 | +56.6% | 0.16% | -3.1% |
| Q1 2021 | $967,000 | +51.6% | 549,624 | +68.1% | 0.16% | +53.8% |
| Q4 2020 | $638,000 | +14.3% | 327,052 | +40.1% | 0.10% | +11.8% |
| Q3 2020 | $558,000 | +59.9% | 233,425 | +92.5% | 0.09% | +5.7% |
| Q1 2020 | $349,000 | +89.7% | 121,258 | +163.1% | 0.09% | +319.0% |
| Q4 2019 | $184,000 | – | 46,084 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |